Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
03/2014
03/26/2014CN103664787A Alkyne heteraromatic ring compound and application thereof
03/26/2014CN103664769A Synthesis method of dipyridyl derivative or analogue
03/26/2014CN103664749A Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/26/2014CN102816125B Contrast agent
03/25/2014US8680273 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
03/25/2014US8680100 Sulfonylhydrazide compounds for treating proliferative disorders
03/25/2014US8680094 1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
03/25/2014US8679773 Kits pertaining to analyte determination
03/25/2014CA2825497A1 Radioactive fluorine-labeled quinoxaline compound
03/25/2014CA2665428C Hdac inhibitors
03/20/2014WO2014041144A1 Crystalline compounds
03/20/2014US20140081019 Process for the preparation of deuterated compounds containing n-alkyl groups
03/20/2014US20140080831 Compounds useful for treating cancer
03/20/2014US20140080824 Structure-guided identification of binding interactions of human laminin receptor precursor with laminin and identification of compounds that affect binding
03/20/2014US20140080800 Inhibitors of Histone Deacetylase
03/19/2014EP2707377A2 Metalloinsertor complexes targeted to dna mismatches
03/19/2014CN103649019A Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
03/19/2014CN103641752A Aromatic carboxylic acid-p-methylsulfonyl phenol ester compound and preparation method and application thereof
03/19/2014CN101952258B Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
03/18/2014US8674101 Nucleophilic fluorination of aromatic compounds
03/18/2014US8674097 Quinoxalinedione derivatives useful as activators of AMPK-activated protein kinase
03/18/2014US8673915 P 2×4 receptor antagonist
03/18/2014US8673908 Kynurenine production inhibitor
03/13/2014WO2014039748A1 Isotopically enriched arylsulfonamide ccr3 antagonists
03/13/2014WO2014039551A1 Preparation of dihydroxyethyl piperazine
03/13/2014WO2014038666A1 Process for producing optically active amine
03/13/2014US20140073789 Biological Buffers with Wide Buffering Ranges
03/13/2014US20140073651 Benzamide derivatives as p2x7 receptor antagonists
03/13/2014US20140073649 Isotopically enriched arylsulfonamide ccr3 antagonists
03/13/2014US20140073632 Treating protein folding disorders with small molecule cftr correctors
03/13/2014US20140072512 Perylenequinone derivatives and uses thereof
03/12/2014CN103626709A Ligustrazine phosphate compound and drug composition containing ligustrazine phosphate compound and ginkgo leaf effective ingredients
03/12/2014CN101367748B Amide derivatives, process for production of same, and method for application thereof as insecticide
03/11/2014US8669363 Quinoxaline compounds and derivatives
03/11/2014US8669257 Phenazine derivatives and uses thereof as potassium channel modulators
03/06/2014WO2013063468A8 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres
03/06/2014US20140066446 2,5-disubstituted arylsulfonamide ccr3 antagonists
03/06/2014US20140066369 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
03/05/2014CN102408384B Improved synthesis method of quinocetone
03/04/2014US8664392 Pyrazine derivatives for bioconjugation
03/04/2014US8664391 Amide compounds as boosters of antivirals
03/04/2014US8664221 Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent
02/2014
02/27/2014WO2014031012A1 Novel prodrugs and methods of use thereof
02/27/2014WO2014029726A1 Novel phenyl-pyridine/pyrazine amides for the treatment of cancer
02/27/2014US20140057890 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2014US20140057889 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2014DE10322191B4 N-sulfonylierte Aminosäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung N-sulfonylated amino acid derivatives, processes for their preparation and their use
02/26/2014CN103607895A Cyclohexanone compounds and herbicides comprising same
02/26/2014CN103601674A Compounds for inhibiting dipeptide kininase, preparation method and applications thereof
02/26/2014CN102036961B Pyridines and pyrazines as inhibitors of PI3K
02/26/2014CN101547689B Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
02/25/2014CA2575645C Soluble amide & ester pyrazinoylguanidine sodium channel blockers
02/20/2014WO2014028479A1 Quinoxaline derivatives as gpr6 modulators
02/19/2014CN103588715A Synthetic method for 1-methyl-3-phenylpiperazine
02/19/2014CN102070539B 1-oxo-2-methyl-3-(1-ethoxyl)-quinoxaline and preparation method and application thereof
02/18/2014US8653263 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
02/18/2014US8653260 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
02/18/2014US8653085 Diketopiperazine salts for drug delivery and related methods
02/13/2014US20140045842 Method for treating an inflammatory disease by administering a 1,2,3,4-tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent
02/13/2014US20140044802 Compounds useful as inhibitors of atr kinase and combination therapies thereof
02/12/2014CN103582633A Nitrogenated heterocyclic compound and agricultural or horticultural bactericidal agent
02/12/2014CN103570710A Praziquantel preparation process
02/12/2014CN103570629A Benzanthracene derivatives containing pyrimidinyl, pyrazinyl or triazinyl groups and applications thereof
02/12/2014CN103570628A Benzoindenofluorene derivative containing pyrimidyl or pyrazinyl or triazinyl group, and its application
02/12/2014CN103570627A Indenofluorene derivative containing pyrimidyl or pyrazinyl or triazinyl group, and its application
02/11/2014US8648070 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
02/11/2014CA2756893C Improved method for preparing dipeptidyl peptidase-iv inhibitor and intermediate
02/11/2014CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
02/06/2014WO2014019186A1 Antidiabetic tricyclic compounds
02/06/2014WO2014019023A1 α7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I
02/06/2014US20140039191 Fluorescent Pyrazine Derivatives and Methods of Using the Same in Assessing Renal Function
02/06/2014US20140039189 Novel process for the preparation of acylguanidines and acylthioureas
02/06/2014US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
02/06/2014US20140038945 Piperazine pde4 inhibitors and uses thereof
02/05/2014EP2691377A1 Aminoquinoxaline derivatives for treatment of neurodegenerative diseases
02/05/2014CN103554039A N-2-pyrazine sulfonylated amino acid and synthesis method thereof
02/05/2014CN103554011A Anthracene containing derivative as well as preparation method and application thereof
02/05/2014CN103550215A Applications of peptides compound in rhizome sparganii
02/04/2014US8642808 Bis-aryl sulfonamides
02/04/2014US8642761 Method for producing 3-amidinophenylalanine derivatives
02/04/2014US8642596 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses
02/04/2014US8642281 Coelenterazine analogues and coelenteramide analogues
01/2014
01/30/2014WO2013006734A8 Substituted 4-phenoxyphenol analogs as modulators of proliferating cell nuclear antigen activity
01/30/2014US20140031371 Poly aromatic sodium channel blockers
01/30/2014US20140031370 Amide derivatives, process for preparation thereof and use thereof as insecticide
01/30/2014US20140031367 Delta opioid receptor agonist compounds
01/30/2014US20140031290 Novel glp-1 receptor stabilizers and modulators
01/29/2014CN103539749A Phenanthrene quinoxaline fluorescent compound and preparation method and application thereof, and electroluminescent device
01/29/2014CN103537283A Catalyst for synthesizing dimethyl-pyrazine by taking glycerin as raw material
01/29/2014CN101139267B White black falsehellebore alcohol derivative, analogue and preparation method and use thereof
01/28/2014US8637658 Non-fluorescent quencher compounds and biomolecular assays
01/28/2014US8637522 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
01/28/2014US8637513 Heterocycle phenyl amide T-type calcium channel antagonists
01/28/2014US8637497 AZA spiro alkane derivatives as inhibitors of metalloproteases
01/28/2014CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression
01/28/2014CA2508170C Pyrazine-based tubulin inhibitors
01/23/2014WO2014014310A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same
01/23/2014WO2013181232A3 Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
01/23/2014US20140024832 Method for producing dichloropyrazine derivative
01/22/2014CN103534242A Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 187